These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15885371)

  • 1. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis.
    Pérez-Aguilar F; Burguera JA; Benlloch S; Berenguer M; Rayón JM
    J Hepatol; 2005 Jun; 42(6):947-9. PubMed ID: 15885371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
    Kono S; Suzuki H; Takahashi K; Takahashi Y; Shirakawa K; Murakawa Y; Yamaguchi S; Miyajima H
    Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR
    Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
    Kuhn J; Bewermeyer H; Miyajima H; Takahashi Y; Kuhn KF; Hoogenraad TU
    Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral hemosiderosis related to hereditary ceruloplasmin deficiency. Clinical familial case study].
    Servan J; Elghozi D; Gaynot S; Duclos H
    Rev Neurol (Paris); 1998 Feb; 154(2):158-62. PubMed ID: 9773037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system involvement in a rare genetic iron overload disorder.
    Bethlehem C; van Harten B; Hoogendoorn M
    Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of aceruloplasminemia presenting as cerebellar ataxia with homozygous mutation nt2602 delG].
    Nagata M; Takiyama Y; Shimazaki H; Nakano I; Miyajima H
    No To Shinkei; 2004 Oct; 56(10):885-9. PubMed ID: 15609677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High brain iron level in asymptomatic carriers of heterozygous ceruloplasmin gene mutations.
    Chen Q; Chen XP; Zou L; Zhou D; Gong QY; Burgunder JM; Shang HF
    Mov Disord; 2008 Apr; 23(6):916-7. PubMed ID: 18311828
    [No Abstract]   [Full Text] [Related]  

  • 11. Cys-881 is essential for the trafficking and secretion of truncated mutant ceruloplasmin in aceruloplasminemia.
    Kono S; Suzuki H; Oda T; Shirakawa K; Takahashi Y; Kitagawa M; Miyajima H
    J Hepatol; 2007 Dec; 47(6):844-50. PubMed ID: 17637479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights.
    Loréal O; Turlin B; Pigeon C; Moisan A; Ropert M; Morice P; Gandon Y; Jouanolle AM; Vérin M; Hider RC; Yoshida K; Brissot P
    J Hepatol; 2002 Jun; 36(6):851-6. PubMed ID: 12044538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic iron overload diseases: a deeply changing world].
    Brissot P; Troadec MB; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Jouanolle AM; Loréal O
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S298-303. PubMed ID: 17373274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional relevance of ceruloplasmin mutations in Parkinson's disease.
    Hochstrasser H; Tomiuk J; Walter U; Behnke S; Spiegel J; Krüger R; Becker G; Riess O; Berg D
    FASEB J; 2005 Nov; 19(13):1851-3. PubMed ID: 16150804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus.
    Logan JI; Harveyson KB; Wisdom GB; Hughes AE; Archbold GP
    QJM; 1994 Nov; 87(11):663-70. PubMed ID: 7820540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aceruloplasminemia.
    Gitlin JD
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aceruloplasminemia - a genetic iron storage disease].
    Ocran KW; Schmidt HH
    Z Gastroenterol; 2002 Jun; 40(6):479-81. PubMed ID: 12055669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.